Intellipharmaceutics International Inc.
IPCIF · OTC
8/31/2023 | 5/31/2023 | 2/28/2023 | 11/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $400 | $159 | $70 | $84 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $268 | $602 | $480 | $389 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $194 | $192 | $186 | $19 |
| Total Curr. Assets | $862 | $953 | $735 | $493 |
| Property Plant & Equip (Net) | $704 | $782 | $860 | $940 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$0 | -$0 | -$0 | -$1 |
| Total NC Assets | $704 | $782 | $860 | $940 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,566 | $1,735 | $1,595 | $1,432 |
| Liabilities | – | – | – | – |
| Payables | $3,859 | $3,673 | $3,816 | $3,765 |
| Short-Term Debt | $2,218 | $2,244 | $2,299 | $2,326 |
| Tax Payable | $29 | $29 | $29 | $29 |
| Deferred Revenue | $214 | $0 | $0 | $0 |
| Other Curr. Liab. | $4,262 | $3,103 | $2,569 | $2,124 |
| Total Curr. Liab. | $14,442 | $12,722 | $12,528 | $12,009 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $14,442 | $12,722 | $12,528 | $12,009 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $49,176 | $49,176 | $49,176 | $49,176 |
| Retained Earnings | -$107,433 | -$105,544 | -$105,490 | -$105,134 |
| AOCI | $284 | $284 | $284 | $284 |
| Other Equity | $45,097 | $45,097 | $45,097 | $45,097 |
| Total Equity | -$12,876 | -$10,987 | -$10,932 | -$10,577 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,566 | $1,735 | $1,595 | $1,432 |
| Net Debt | $1,818 | $2,085 | $2,229 | $2,242 |